Alnylam Pharmaceuticals, Inc. (ALNY)
328.16
-3.08
(-0.93%)
USD |
NASDAQ |
Feb 06, 16:00
325.00
-3.16
(-0.96%)
After-Hours: 20:00
Alnylam Pharmaceuticals SG&A Expense (TTM) : 1.181B for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Insmed, Inc. | 631.20M |
| Biogen, Inc. | 2.434B |
| Pfizer Inc. | 13.79B |
| Eli Lilly & Co. | 11.09B |
| Bristol Myers Squibb Co. | 7.267B |